A Study to Learn About the Safety of BESPONSA Injection in Pediatric Patients With Acute Lymphocytic Leukemia.
Clinical trial NCT06476665 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06476665
- Sponsor
- Pfizer
- Status
- ACTIVE_NOT_RECRUITING
- Study type
- OBSERVATIONAL
- Start date
- 2024-11-07
- Primary completion
- 2029-06-22
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.